Learn about CVE-2020-16222 affecting Philips patient monitoring devices due to improper authentication. Discover the impact, affected systems, exploitation, mitigation steps, and Philips' solutions.
Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, PerformanceBridge Focal Point Version A.01, and IntelliVue patient monitors MX100, MX400-MX850, MP2-MP90 Versions N and prior, X3, and X2 are affected by an improper authentication vulnerability.
Understanding CVE-2020-16222
This CVE involves vulnerabilities in Philips patient monitoring devices due to improper authentication.
What is CVE-2020-16222?
In PICiX and PerformanceBridge Focal Point versions, the software fails to adequately verify the identity claimed by an actor, leading to potential security risks.
The Impact of CVE-2020-16222
The vulnerability could allow unauthorized actors to access patient monitoring systems, compromising patient data confidentiality and system integrity.
Technical Details of CVE-2020-16222
This section provides detailed technical information about the vulnerability.
Vulnerability Description
The software in affected versions does not sufficiently verify the claimed identity, leaving systems vulnerable to unauthorized access.
Affected Systems and Versions
Exploitation Mechanism
Unauthorized actors can exploit the lack of proper authentication to gain unauthorized access to the patient monitoring devices.
Mitigation and Prevention
Learn how to mitigate and prevent the CVE-2020-16222 vulnerability.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates